Chapter 48: Clinical Biochemistry Applications
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Clinical Biochemistry Applications details the statistical foundation of interpreting laboratory data, explaining how reference ranges are established based on Gaussian distributions within healthy populations, typically defined as the mean plus or minus two standard deviations. The text rigorously distinguishes between the analytical validation of a method—characterized by precision, accuracy, detection limits, and specificity—and its clinical utility, which is evaluated through diagnostic sensitivity, diagnostic specificity, and positive or negative predictive values. A variety of analytical techniques are explored, including absorption spectrophotometry, fluorimetry, ion-specific electrodes, and advanced methods like high-pressure liquid chromatography (HPLC) and mass spectrometry, which underpin the fields of metabolomics and metabonomics. The chapter elucidates the biochemical principles behind enzyme-based assays, describing how enzymes are used as highly specific reagents to measure analytes like glucose (distinguishing glucose oxidase methods from nonspecific reduction tests) and how serum enzyme levels serve as markers for tissue damage when measured under conditions of substrate excess. Furthermore, it covers the assessment of vitamin nutritional status through enzyme activation coefficients and explains the mechanics of ligand-binding assays, including radioimmunoassay and enzyme-linked immunosorbent assays (ELISA). Practical applications such as point-of-care dipstick testing and newborn screening for inborn errors of metabolism like phenylketonuria are also discussed. Finally, the summary categorizes specific organ function tests, detailing markers for renal function (such as creatinine clearance and proteinuria), liver integrity (bilirubin, aminotransferases like ALT and AST), thyroid status (TSH and thyroxine), adrenal cortisol regulation (dexamethasone suppression), and cardiovascular risk factors, including lipid profiles and cardiac biomarkers like troponin and creatine kinase MB.